FDA's role in balancing innovation, regulation, safety during pandemic

Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory "agility" during the COVID-19 pandemic.

Women In Health ITResource Center

Stay Informed

Subscribe today to receive our FREE monthly e-newsletter